Clopidogrel with or without Omeprazole in Coronary Artery Disease
Clopidogrel with or without Omeprazole in Coronary Artery Disease
About this item
Full title
Author / Creator
Publisher
Waltham, MA: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
Waltham, MA: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In patients receiving dual antiplatelet therapy, omeprazole reduced the risk of upper-GI toxic effects but did not increase the risk of cardiovascular events; statistical power to assess cardiovascular events was low, however, so the findings are not definitive.
On the basis of data from several studies, clopidogrel has become the second most co...
Alternative Titles
Full title
Clopidogrel with or without Omeprazole in Coronary Artery Disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_808460743
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_808460743
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1007964
